Paper Details

  1. Home
  2. Paper Details

Economic Burden of Toxicities Associated with Treating Metastatic Melanoma in the United States.

Author: BarberBeth, BilirS Pinar, MaQiufei, MunakataJulie, WehlerElizabeth, ZhaoZhongyun

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Managing treatment-related adverse events in patients with metastatic melanoma is associated with substantial costs. The most common adverse events were neutropenia, vomiting, anemia, and cutaneous squamous-cell carcinoma.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Little has been reported on the costs of managing the adverse events (AEs) associated with current therapies for patients with regional or distant metastatic melanoma. OBJECTIVES: To identify treatment-related AEs in patients with metastatic melanoma and to estimate the associated costs...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004818/

データ提供：米国国立医学図書館（NLM）

Economic Burden of Toxicities Associated with Treating Metastatic Melanoma in the United States

Metastatic melanoma is a formidable foe, like a desert sandstorm that can wreak havoc on the body. This study explores the economic burden of managing toxicities associated with treatments for metastatic melanoma in the United States.

The study found that the costs of managing treatment-related adverse events (AEs) in patients with metastatic melanoma are substantial, with the highest treatment costs for neutropenia, headache, and peripheral neuropathy. The highest mean inpatient costs were associated with acute myocardial infarction, sepsis, and coma.

Navigating the Costs of Cancer Treatment

The study highlights the significant economic burden associated with managing toxicities related to metastatic melanoma treatment. It suggests that developing more effective and safer treatment options could help reduce these costs and improve the overall cost-effectiveness of melanoma care. This is like finding a more efficient way to navigate a desert, reducing the resources needed for survival.

A Need for Improved Treatment Options

This study underscores the need for improved treatment options for metastatic melanoma. Developing therapies with fewer adverse effects could significantly reduce the economic burden associated with managing these side effects, ultimately improving the overall cost-effectiveness of melanoma care. This is like finding a more sustainable oasis that requires less effort to maintain, allowing for a more efficient journey across the desert.

Dr. Camel's Conclusion

This study sheds light on the hidden costs of cancer treatment. The economic burden of managing toxicities related to metastatic melanoma treatment is substantial, highlighting the need for more effective and safer therapies. This research is a reminder that in the desert of cancer care, finding sustainable and cost-effective solutions is crucial for improving patient outcomes.

Date :
  1. Date Completed 2016-09-30
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

27688833

DOI: Digital Object Identifier

PMC5004818

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.